Estimation issues in clinical trials and overviews.

There is a general move towards greater emphasis on point and interval estimates of treatment effect in reporting of clinical trials, so that significance testing plays a lesser role. In this article we examine a number of issues which affect the use and interpretation of conventional estimation methods. Should we accept or avoid the stereotypes of 95 per cent confidence? Should the abstract of a trial report include confidence intervals for major endpoints? Are frequentist confidence intervals being interpreted correctly, and should Bayesian probability intervals be more widely used in trial reports? Does the timing of publication, such as early stopping because of a large observed treatment difference, lead to exaggerated point and interval estimates? How can we produce realistic estimates from subgroup analyses? Is publication bias seriously affecting our ability to obtain unbiased estimates? Is the emphasis on estimation methods a powerful tool for encouraging larger sample sizes? Can we resolve the controversy concerning fixed or random effects models for estimation in overviews of related trials? Our arguments are illustrated by results from recent trials in cardiovascular disease.

[1]  T C Chalmers,et al.  A comparison of statistical methods for combining event rates from clinical trials. , 1989, Statistics in medicine.

[2]  S. Pocock,et al.  Stopping rules and estimation problems in clinical trials. , 1988, Statistics in medicine.

[3]  J. Cruickshank,et al.  Treating hypertension in black compared with white non-insulin dependent diabetics: a double blind trial of verapamil and metoprolol. , 1988, BMJ.

[4]  A. M. Skene,et al.  TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTION Anglo-Scandinavian Study of Early Thrombolysis (ASSET) , 1988, The Lancet.

[5]  S. Evans,et al.  The end of the p value? , 1988, British heart journal.

[6]  C. Begg,et al.  Publication bias : a problem in interpreting medical data , 1988 .

[7]  R. Doll,et al.  Randomised trial of prophylactic daily aspirin in British male doctors , 1988, British medical journal.

[8]  G Berry,et al.  Statistical significance and confidence intervals , 1986, The British journal of clinical practice.

[9]  S. Pocock,et al.  Statistical problems in the reporting of clinical trials. A survey of three medical journals. , 1987, The New England journal of medicine.

[10]  N L Geller,et al.  Interim analyses in randomized clinical trials: ramifications and guidelines for practitioners. , 1987, Biometrics.

[11]  C Poole,et al.  Beyond the confidence interval. , 1987, American journal of public health.

[12]  W. Thompson,et al.  Statistical criteria in the interpretation of epidemiologic data. , 1987, American journal of public health.

[13]  John Whitehead,et al.  On the bias of maximum likelihood estimation following a sequential test , 1986 .

[14]  R. Simes.  Publication bias: the case for an international registry of clinical trials. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[16]  M J Langman,et al.  Towards estimation and confidence intervals. , 1986, British medical journal.

[17]  M. Gardner,et al.  Confidence intervals rather than P values: estimation rather than hypothesis testing. , 1986, British medical journal.

[18]  P. O'Brien,et al.  Confidence intervals following group sequential tests. , 1986, Controlled clinical trials.

[19]  D. Berry,et al.  Interim analyses in clinical trials: classical vs. Bayesian approaches. , 1985, Statistics in medicine.

[20]  A. Shore,et al.  Lack of effect of oral magnesium on high blood pressure: a double blind study. , 1985, British medical journal.

[21]  R. Peto,et al.  Beta blockade during and after myocardial infarction: an overview of the randomized trials. , 1985, Progress in cardiovascular diseases.

[22]  S. Pocock.  Current issues in the design and interpretation of clinical trials. , 1985, British medical journal.

[23]  C B Begg,et al.  A measure to aid in the interpretation of published clinical trials. , 1985, Statistics in medicine.

[24]  T R Fleming,et al.  Designs for group sequential tests. , 1984, Controlled clinical trials.

[25]  A A Tsiatis,et al.  Exact confidence intervals following a group sequential test. , 1984, Biometrics.

[26]  T. Louis.  Estimating a population of parameter values using Bayes and empirical Bayes methods , 1984 .

[27]  A Donner,et al.  A Bayesian approach to the interpretation of subgroup results in clinical trials. , 1982, Journal of chronic diseases.

[28]  I. Holme,et al.  EFFECT OF DIET AND SMOKING INTERVENTION ON THE INCIDENCE OF CORONARY HEART DISEASE Report from the Oslo Study Group of a Randomised Trial in Healthy Men , 1981, The Lancet.

[29]  P. Armitage,et al.  Repeated Significance Tests on Accumulating Data , 1969 .

[30]  P. Armitage,et al.  NUMERICAL STUDIES IN THE SEQUENTIAL ESTIMATION OF A BINOMIAL PARAMETER , 1958 .

[31]  W. G. Cochran.  The combination of estimates from different experiments. , 1954 .